These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1830 related articles for article (PubMed ID: 33554684)

  • 1. SARS-CoV-2 invasion of the central nervous: a brief review.
    Siddiqui R; Mungroo MR; Khan NA
    Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
    Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
    J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
    Romero A; Ramos E; López-Muñoz F; Gil-Martín E; Escames G; Reiter RJ
    Cell Mol Neurobiol; 2022 Apr; 42(3):489-500. PubMed ID: 32772307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
    Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
    Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.
    Meinhardt J; Radke J; Dittmayer C; Franz J; Thomas C; Mothes R; Laue M; Schneider J; Brünink S; Greuel S; Lehmann M; Hassan O; Aschman T; Schumann E; Chua RL; Conrad C; Eils R; Stenzel W; Windgassen M; Rößler L; Goebel HH; Gelderblom HR; Martin H; Nitsche A; Schulz-Schaeffer WJ; Hakroush S; Winkler MS; Tampe B; Scheibe F; Körtvélyessy P; Reinhold D; Siegmund B; Kühl AA; Elezkurtaj S; Horst D; Oesterhelweg L; Tsokos M; Ingold-Heppner B; Stadelmann C; Drosten C; Corman VM; Radbruch H; Heppner FL
    Nat Neurosci; 2021 Feb; 24(2):168-175. PubMed ID: 33257876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
    Hu J; Jolkkonen J; Zhao C
    Neurosci Biobehav Rev; 2020 Dec; 119():184-193. PubMed ID: 33091416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
    Erickson MA; Rhea EM; Knopp RC; Banks WA
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
    Li YC; Zhang Y; Tan BH
    J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier.
    de Sousa AK; Magalhães DA; Ferreira JDS; Barbosa ALDR
    Med Hypotheses; 2020 Nov; 144():110213. PubMed ID: 33254519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
    Dey J; Alam MT; Chandra S; Gupta J; Ray U; Srivastava AK; Tripathi PP
    J Med Virol; 2021 Mar; 93(3):1296-1303. PubMed ID: 32964419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
    Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
    Front Immunol; 2021; 12():697329. PubMed ID: 34386007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    Yashavantha Rao HC; Jayabaskaran C
    J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
    Zhao Y; Li W; Lukiw W
    Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.